• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Tolero Presents Biomarker Identification Strategies for Invg Agents Alvocidib

    PRNEWSWIRE

    Tolero Pharmaceuticals Presents Findings from Phase 1 Zella 101 Clinical Study

    PRNEWSWIRE

    Tolero Pharmaceuticals Announces First Patient Dosed in Phase 2 Zella 202 Study

    PR NEWSWIRE

    AbbVie, Tolero team up to test Venclexta combo in AML

    FIERCE BIOTECH

    Tolero Pharmaceuticals Receives European Medicines Agency Orphan Drug Designation For Alvocidib For The Treatment Of Acute Myeloid Leukemia

    BIOSPACE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.